Dementia Protocol Science Overview
This guide covers why better dementia screeners and assessments are needed, how the Creyos dementia protocol meets those needs, and details about the science and validity behind our approach. Answer questions like "Will biomarkers replace cognitive testing?" and discover a screener that's faster and more thorough than traditional tools.
Dementia Protocol Science Overview: Read the Full Text Now
The Creyos dementia protocol combines cognitive, functional, and behavioral testing to provide information about symptoms of mild cognitive impairment and dementia. This guide reviews the science behind the assessments, including:
- The link between age and cognitive decline
- The tasks used in this protocol
- How patients are classified based on standard diagnostic criteria.
"We really wanted to help our Oak Street primary care providers understand the exact diagnostic criteria for dementia. Creyos has been a perfect fit for us because it has the objective impairment measures with both the screener and the assessment. But then also importantly to our primary care providers, there's a questionnaire on functional decline as well. And that, of course, is required for DSM-5 for dementia diagnosis."
Dr. Justin Hunt
Senior Medical Director of Behavioral Health
Oak Street Health
Our product experts are ready to speak with you
Creyos Health is backed by over 30 years of research and 400+ peer reviewed studies. The platform can help you measure the cognitive effects of neurological conditions, such as dementia, brain injury, Parkinson's, and more.
Request a demo today and see how you can use Creyos to deliver better patient care.